Literature DB >> 2421806

Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses.

T N Wight, M G Kinsella, A Keating, J W Singer.   

Abstract

Proteoglycans within the extracellular matrix of human bone marrow have been implicated in the process of hematopoiesis, but little is known about the structure and composition of these macromolecules in this tissue. Hematopoietically active human long-term bone marrow cultures were incubated with medium containing 35S-sulfate and 3H-glucosamine as labeling precursors. Proteoglycans present in the medium and cell layer were extracted with 4 mol/L guanidine HCI and purified by diethylaminoethyl (DEAE)-Sephacel ion exchange and molecular sieve chromatography. Both culture compartments contain a large chondroitin sulfate proteoglycan (MI, CI) that eluted in the void volume of a Sepharose CL-4B column and contained glycosaminoglycan chains of molecular weight (mol wt) approximately 38,000. A second population of sulfate-labeled material was identified as a broad heterogenous peak (MII, CII) that was included on Sepharose CL-4B at Kav = 0.31. This material when chromatographed on Sepharose CL-6B could be further separated into a void peak (MIIa, CIIa) and an included peak eluting at Kav = 0.39 (MIIb, CIIb). The void peaks (MIIa, CIIa) were susceptible to chondroitinase ABC digestion (99%) but slightly less susceptible to chondroitinase AC digestion (90%). Papain digestion of these peaks revealed them to be proteoglycans with glycosaminoglycan chains of mol wt approximately 38,000. The included peaks on Sepharose CL-6B (MIIb, CIIb) from both medium and cell layer compartments resisted digestion with papain, indicating the presence of glycosaminoglycan chains of mol wt approximately 38,000 either free or attached to a small peptide. Although this material was susceptible to chondroitinase ABC (98%), it was considerably less susceptible to chondrotinase AC (approximately 60%), indicating that it contained dermatan sulfate. A small amount of heparan sulfate proteoglycan was also identified but constituted only approximately 10% of the total sulfated proteoglycan extracted from these cultures. Additionally, approximately 40% of the incorporated 3H-activity radioactivity was present as hyaluronic acid. Electron microscopy revealed a layer of adherent cells covered by a mat containing ruthenium red-positive granules that were connected by thin filaments. The extracellular matrix layer above the adherent cells contained a mixture of hematopoietic cells. Chondroitinase ABC treatment of the cultures completely removed the ruthenium red-positive granules overlying the cells and resulted in a loss of approximately 70% of the 35S-sulfate-labeled material from the cell layer.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421806

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells.

Authors:  Diah S Bramono; David A Rider; Sadasivam Murali; Victor Nurcombe; Simon M Cool
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

2.  Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments.

Authors:  Marina C Prewitz; F Philipp Seib; Malte von Bonin; Jens Friedrichs; Aline Stißel; Christian Niehage; Katrin Müller; Konstantinos Anastassiadis; Claudia Waskow; Bernard Hoflack; Martin Bornhäuser; Carsten Werner
Journal:  Nat Methods       Date:  2013-06-23       Impact factor: 28.547

Review 3.  Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.

Authors:  Marina Konopleva; Yoko Tabe; Zhihong Zeng; Michael Andreeff
Journal:  Drug Resist Updat       Date:  2009-07-25       Impact factor: 18.500

4.  Proteoglycan synthesis in human and murine haematopoietic progenitor cell lines: isolation and characterization of a heparan sulphate proteoglycan as a major proteoglycan from the human haematopoietic cell line TF-1.

Authors:  G Stöcker; Z Drzeniek; U Just; W Ostertag; B Siebertz; H Greiling; H D Haubeck
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

5.  Proteoglycan synthesis in haematopoietic cells: isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5.

Authors:  Z Drzeniek; B Siebertz; G Stöcker; U Just; W Ostertag; H Greiling; H D Haubeck
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

6.  Immunochemical characterization and ultrastructural localization of chondroitin sulfates and keratan sulfate in embryonic chick bone marrow.

Authors:  J M Sorrell; F Mahmoodian; B Caterson
Journal:  Cell Tissue Res       Date:  1988-06       Impact factor: 5.249

7.  Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells.

Authors:  B Siebertz; G Stöcker; Z Drzeniek; S Handt; U Just; H D Haubeck
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 8.  DNA methylation and demethylation link the properties of mesenchymal stem cells: Regeneration and immunomodulation.

Authors:  Tian-Yi Xin; Ting-Ting Yu; Rui-Li Yang
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

Review 9.  The extracellular matrix of the hematopoietic microenvironment.

Authors:  G Klein
Journal:  Experientia       Date:  1995-09-29

10.  Two different functions for CD44 proteins in human myelopoiesis.

Authors:  J Moll; S Khaldoyanidi; J P Sleeman; M Achtnich; I Preuss; H Ponta; P Herrlich
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.